Paper Details

  1. Home
  2. Paper Details

Direct oral anticoagulants (DOACs).

Author: RondinaMatthew T, VazquezSara

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

Macular hole formation after anti-vascular endothelial growth factor therapy is a rare but possible complication.
Paper Details　
Original Abstract of the Article :
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1358863X15600256

データ提供：米国国立医学図書館（NLM）

Direct Oral Anticoagulants (DOACs): Navigating the Desert of Blood Thinners

The world of blood thinners is a complex desert, with various medications offering different approaches to managing blood clotting. This research explores the emergence of a new class of blood thinners, direct oral anticoagulants (DOACs), and their potential benefits over warfarin. It's like discovering a new oasis in the desert of blood thinners, offering a potential alternative for managing blood clotting.

The study highlights the need for careful consideration when choosing a blood thinner, based on individual patient factors. It's like selecting the right camel for a journey across the desert, taking into account the terrain and the traveler's needs.

DOACs: A New Oasis for Blood Thinners

The study points to the potential advantages of DOACs, which may have fewer side effects and require less frequent monitoring than warfarin. It's like finding a smoother path through the desert of blood thinners, offering a more comfortable and convenient journey for patients.

Understanding Blood Thinners

This research reminds us that the desert of health is full of ongoing discoveries, and that staying informed about the latest advancements is crucial for managing chronic conditions. It's like being a wise traveler in the desert, keeping abreast of the changing landscape to navigate the terrain safely and effectively.

Dr. Camel's Conclusion

This research is a testament to the ongoing progress in medical science. It's a reminder that the desert of health is a dynamic environment, where new discoveries and innovations are constantly emerging.

Date :
  1. Date Completed 2016-09-16
  2. Date Revised 2016-11-26
Further Info :

Pubmed ID

26285587

DOI: Digital Object Identifier

10.1177/1358863X15600256

Related Literature

Article Analysis
・Side Effects of edoxaban
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.